Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Sanofi’s adoption of the Accumulus platform marks another move towards fit-for-purpose technology that ensures secure, real-time global regulatory connectivity. Many of the NRAs involved in the Sanofi ...

Sanofi SA (NASDAQ:SNY ... While CD&R has emerged as the frontrunner, PAI and its partners, including Singapore’s GIC and the Abu Dhabi Investment Authority, argued that their French roots ...

Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing ...

PAI Partners is working with sovereign wealth funds Abu Dhabi Investment Authority and Singapore’s GIC Pte on the bid for the Sanofi unit. On Wednesday, Reuters reported that Sanofi’s (SNY ...

PARIS, Oct 16 (Reuters) - French unions have called on workers at Sanofi (SASY.PA), opens new tab to strike from Thursday to protest a planned sale of the pharmaceutical group's consumer health ...

A consortium including French private equity firm PAI Partners has raised its offer for Sanofi's consumer health ... among foreign investors such as Singapore's GIC and the Abu Dhabi Investment ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the matter, an unexpected twist in one of the biggest deals in Europe this year.

The possibility that France may block a deal between Sanofi and the US private equity ... it is investing alongside foreign players such as Singapore's GIC and the Abu Dhabi Investment Authority.

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...